Joo Hoon Kim

24PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Dec 26, 2025
Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre Study.

Jung Sun Kim, Jeffrey Wong, San-Chi Chen

|Dec 18, 2025
Elevated antidrug antibodies against atezolizumab and associated clinical outcomes in advanced non-small-cell lung cancer.

Miran Jang, Chan Kim, So Jung Kong

|Jun 09, 2025
Organ-Specific Responses to Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study.

Jung Sun Kim, Youngun Kim, Beodeul Kang

|Oct 22, 2024
Oral reovirus reshapes the gut microbiome and enhances antitumor immunity in colon cancer.

Won Suk Lee, Seung Joon Lee, Hye Jin Lee

|Apr 09, 2024
Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab.

Yun Beom Sang, Chaeryoung Lee, Seul-Gi Kim

|Sep 25, 2023
PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasis.

Eun-Jin Go, Hannah Yang, Seung Joon Lee

Pageof 4

Frequent Collaborators

14 joint publications

Hong Jae Chon

4 joint publications

Won Suk Lee

4 joint publications

Hannah Yang

2 joint publications

Wooram Park